chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cough, Dyspnoea, Fatigue
Clinical narrative: Fatigue; dyspnea; chest pain; cough; This is a spontaneous report from a contactable consumer (patient himself). A 48-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER0170, Expiry date: not reported), via an unspecified route of administration, administered in Arm Right on 27Apr2021 at 07:30 (age at vaccination was 48 years) as Dose 2, Single for COVID-19 immunization. Facility of the most recent COVID-19 vaccine was administered was reported as Hospital. The patient's medical history included diabetes. The patient's concomitant medications were not reported. The patient had not received any other vaccines are received within 4 weeks prior to the Covid vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER8729, Expiry date: not reported), via an unspecified route, administered in Right Arm on 06Apr2021 at 07:30 (age at vaccination was 48 years) as Dose 1, Single for COVID-19 immunization. On 28Apr2021 at 07:00 the patient experienced fatigue, dyspnea, chest pain, cough. Since the vaccination, the patient has not been tested for Covid-19. Device date was 03May2021. The outcome of events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Eye swelling, Insomnia, Lip swelling, Pain in extremity
Clinical narrative: 3 days after swelling my legs were extremely sore (wearing socks hurt).; Eyes and Lip swelling 5 days after shot.; Eyes and Lip swelling 5 days after shot.; After swelling, felt dizzy and all over body tingles for 24 - 48 hours.; After swelling, felt dizzy and all over body tingles for 24 - 48 hours.; Suspect lack of sleep working 14 hours multiple days; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 15Apr2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to penicillin and reaction to flu vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received influenza vaccine (MANUFACTURER UNKNOWN) for immunisation on unknown date in 2018 and experienced eyes and lip swelling. On 20Apr2021 at 18:00, 5 days after shot, the patient experienced eyes and lip swelling and had the same type of reaction 3 years ago, 8 hours after a flu shot. The patient felt fine for the first 5 days after shot, then swelling occurred and was treated with benadryl allergy for 24 hours. swelling went away but felt terrible for 5 more days. After swelling, the patient felt dizzy and all over body tingles for 24 to 48 hours. On an unknown date in Apr2021, the patient suspect lack of sleep after working 14 hours multiple days and taking benadryl had something to do with how he felt after swelling. After getting more rest and on 23Apr2021, 3 days after swelling, the patient experienced legs were extremely sore (wearing socks hurt). 5 days after swelling occurred the patient felt ok again. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the lack of sleep, eyes and lip swelling and included treatment with diphenhydramine hydrochloride (BENADRYL). Therapeutic measures were not taken as a result of the felt dizzy, all-over body tingles and legs were extremely sore. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events eyes and lip swelling and legs were extremely sore was resolved on 25Apr2021 and of the events the felt dizzy, all-over body tingles and suspect lack of sleep after working 14 hours multiple days was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: 3 days after swelling my legs were extremely sore (wearing socks hurt).; Eyes and Lip swelling 5 days after shot.; Eyes and Lip swelling 5 days after shot.; After swelling, felt dizzy and all over body tingles for 24 - 48 hours.; After swelling, felt dizzy and all over body tingles for 24 - 48 hours.; Suspect lack of sleep working 14 hours multiple days; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 15Apr2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to penicillin and reaction to flu vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received influenza vaccine (MANUFACTURER UNKNOWN) for immunisation on unknown date in 2018 and experienced eyes and lip swelling. On 20Apr2021 at 18:00, 5 days after shot, the patient experienced eyes and lip swelling and had the same type of reaction 3 years ago, 8 hours after a flu shot. The patient felt fine for the first 5 days after shot, then swelling occurred and was treated with benadryl allergy for 24 hours. swelling went away but felt terrible for 5 more days. After swelling, the patient felt dizzy and all over body tingles for 24 to 48 hours. On an unknown date in Apr2021, the patient suspect lack of sleep after working 14 hours multiple days and taking benadryl had something to do with how he felt after swelling. After getting more rest and on 23Apr2021, 3 days after swelling, the patient experienced legs were extremely sore (wearing socks hurt). 5 days after swelling occurred the patient felt ok again. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the lack of sleep, eyes and lip swelling and included treatment with diphenhydramine hydrochloride (BENADRYL). Therapeutic measures were not taken as a result of the felt dizzy, all-over body tingles and legs were extremely sore. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events eyes and lip swelling and legs were extremely sore was resolved on 25Apr2021 and of the events the felt dizzy, all-over body tingles and suspect lack of sleep after working 14 hours multiple days was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Pain, Pain in extremity
Clinical narrative: Excruciating armpit/breast lymph node pain; Aches; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's thyroiditis, Gastroesophageal Reflux Disease (GERD), anemia, depression and anxiety. The patient was allergic to sulfa and quinolone. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX), levothyroxine sodium (SYNTHROID), bupropion hydrochloride (WELLBUTRIN), escitalopram oxalate (LEXAPRO), vitamin D nos (MANUFACTURER UNKNOWN) and fluticasone propionate (FLONASE); all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 03:30, about 40 hours after the vaccination, the patient experienced excruciating armpit/breast lymph node pain with aches and sore arm. The node pain did not respond to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with NSAIDs (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches and sore arm was recovered on an unknown date in Apr2021 while armpit/breast lymph node pain was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Fatigue, Feeling abnormal, Hyperhidrosis
Clinical narrative: Fever 100; diarrhea; very tired for 3 days; brain was fuzzy; couldn't think right; Sweats; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 28Apr2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, migrane headaches, polyps in colon, diverticulitis and compression fractures in back and allergic reaction to antibiotics (tetracycline). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), prazosin (MANUFACTURER UNKNOWN), CENTRUM SILVER VITAMINS and topiramate (TOPAS); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 08Apr2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 29Apr2021 at 02:00 the patient experienced fever, diarrhea, very tired for 3 days, brain was fuzzy, could not think right and sweats. On the same day (29Apr2021), the patient checked body temperature and the result was 100 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very tired was resolved on 02May2021. The clinical outcome of the events fever, diarrhea, brain was fuzzy, could not think right and sweats were resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Thinking abnormal
Clinical narrative: Fever 100; diarrhea; very tired for 3 days; brain was fuzzy; couldn't think right; Sweats; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 28Apr2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, migrane headaches, polyps in colon, diverticulitis and compression fractures in back and allergic reaction to antibiotics (tetracycline). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), prazosin (MANUFACTURER UNKNOWN), CENTRUM SILVER VITAMINS and topiramate (TOPAS); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 08Apr2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 29Apr2021 at 02:00 the patient experienced fever, diarrhea, very tired for 3 days, brain was fuzzy, could not think right and sweats. On the same day (29Apr2021), the patient checked body temperature and the result was 100 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very tired was resolved on 02May2021. The clinical outcome of the events fever, diarrhea, brain was fuzzy, could not think right and sweats were resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Musculoskeletal stiffness, Pain in extremity, Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 30-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# 660046), at the age of 30, via an unspecified route of administration, in the right arm, on Apr 27, 2021, at 12:00, single dose, for COVID-19 immunisation. Medical history included asthma and allergic to coconut. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications not reported. On Apr 27, 2021, at 14:00, patient experienced arm and injection site pain; some stiffness in muscles and fatigue. The events did not result in doctor or other healthcare professional office/clinic/emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of arm and injection site pain; some stiffness in muscles and fatigue recovered on Apr 27, 2021. No follow-up attempts possible. No further information expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis, Migraine, Musculoskeletal discomfort, Nausea, Pain
Clinical narrative: Tuesday - neck has locked up; Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Friday evening - fever in arm, but otherwise good; Friday evening - fever in arm, but otherwise good; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 23Apr2021 at 14:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, migraine (1-2 per month) and irritable bowel syndrome (IBS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included piroxicam (PAXIL), eszopiclone (LUNESTA), bupropion (BUPROPRION) and lamotrigine (MANUFACTURER UNKNOWN) for unknown indications from an unknown date and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On Friday evening 23Apr2021, the patient experienced fever in arm, but otherwise good. On Sunday (48 hrs) on 25Apr2021 at 16:00, the patient experienced migraine (affected vision, hearing, nausea had pain of course). On Monday 26Apr2021, the patient had another migraine (have never had 2 in a row same symptom but worse). On Tuesday 27Apr2021, the patient's neck had locked up. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever in arm, migraine (affected vision, hearing, nausea had pain of course), neck had locked up was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Visual impairment
Clinical narrative: Tuesday - neck has locked up; Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Friday evening - fever in arm, but otherwise good; Friday evening - fever in arm, but otherwise good; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 23Apr2021 at 14:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, migraine (1-2 per month) and irritable bowel syndrome (IBS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included piroxicam (PAXIL), eszopiclone (LUNESTA), bupropion (BUPROPRION) and lamotrigine (MANUFACTURER UNKNOWN) for unknown indications from an unknown date and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On Friday evening 23Apr2021, the patient experienced fever in arm, but otherwise good. On Sunday (48 hrs) on 25Apr2021 at 16:00, the patient experienced migraine (affected vision, hearing, nausea had pain of course). On Monday 26Apr2021, the patient had another migraine (have never had 2 in a row same symptom but worse). On Tuesday 27Apr2021, the patient's neck had locked up. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever in arm, migraine (affected vision, hearing, nausea had pain of course), neck had locked up was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Brain Fog Continuous.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 05:45(at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, type 2 diabetes mellitus, blood pressure high and cholesterol high. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (TIROSINT), semaglutide (OZEMPIC), lisinopril (MANUFACTURER UNKNOWN), pravastatin (MANUFACTURER UNKNOWN) and colecalciferol (VIT D). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 05Mar2021 at 08:30 as a single dose for COVID-19 immunisation.  On 27Mar2021 the patient experienced brain fog continuous. The patient did not receive any treatment for the event.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event brain fog continuous was not recovered at this time of report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Nightmare
Clinical narrative: Crazy nightmares; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 12:00, the patient experienced crazy nightmares. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event nightmares was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Migraine, Nausea
Clinical narrative: Diarrhea; Nausea; Migraine for two days; Stomach pain; his is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 24Apr2021 at 14:15(at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the arm left on 03Apr2021 at 15:00(at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 00:00, the patient experienced diarrhea, nausea, migraine for two days and stomach pain. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine was resolved on 27Apr2021, while the clinical outcome of the events diarrhea, nausea and stomach pain were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Muscle twitching
Clinical narrative: Muscle twitching in bicep and forearm of the arm in which received the vaccine; Muscle spasms in bicep and forearm of the arm in which received the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 12:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, supraventricular tachycardia and penicillin allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Concomitant medications were not reported. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and aspartame (MANUFACTURER UNKNOWN); both for an unknown indication from unknown dates and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 12:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 09:00, the patient experienced muscle twitching and spasms in bicep and forearm of the arm in which the patient  received the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle twitching and spasms in bicep and forearm of the arm was not recovered at the time of report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Pharyngeal swelling, Urticaria
Clinical narrative: today my mouth got numb; throat swelled until i took A Benadryl; For 3 days i have Been getting hives daily; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 14Apr2021 at 13:30 (at the age of 35-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, it was unknown whether the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 13:30 (at the age of 35-year-old), as a single dose for COVID-19 immunisation.  On 23Apr2021, the patient had been getting hives daily for 3 days and on 27Apr2021 (reported as today), patient's mouth got numb and throat swelled until the patient took Benadryl. The patient had no allergies at all before this shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events mouth got numb and throat swelled and included treatment with diphenhydramine hydrochloride (BENADRYL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event getting hives daily, mouth got numb and throat swelled was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Swelling of left arm; Swelling of left arm, extremely sore and swollen; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 24Apr2021 at 15:00 (at the age of 68-year-old), as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 02Apr2021 at 14:00, as a single dose for COVID-19 immunisation. On 24Apr2021, the patient experienced swelling of left arm, extremely sore and swollen. The patient was still experiencing it into the fourth day (current day) and was not any better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of left arm, extremely sore and swollen was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Started menstruating 14 days earlier; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 20Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included propranolol (MANUFACTURER UNKNOWN), taken for an unknown indication from an unknown date and unknown if ongoing. On 22Apr2021 at 00:00, 2 days after the shot, the patient started menstruating 14 days earlier. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event started menstruating 14 days earlier was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Menstruation irregular, Nausea, Vaccination site pain
Clinical narrative: Headache; Nausea; Pain at the location where the shot was administered; I had period 1 full week early (normally regular), it began the next day after the shot/ might be triggered by the vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 at 10:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 08:00, the patient's period was1 full week early (normally regular), it began the next day after the shot. The patient was not sure why this happened, but thought it might be triggered by the vaccine. Other than this, patient had headache, nausea and pain at the location where the shot was administered. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, pain at the location where the shot was administered and period 1 full week early (normally regular), it began the next day after the shot/ might be triggered by the vaccine was recovered on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: "My" cheeks are red, 24 hours after "I" received the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729 or EB8729) via an unspecified route of administration in the left arm on 26Apr2021 at 13:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, hashimoto's and rosacea. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. On 27Apr2021 at 16:00 the patient's cheeks were red, 24 hours after receiving the vaccine. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event cheeks was red was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: "I" feel tingles on "my"  right hand fingers and right leg; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 21Apr2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 15:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation.  On 24Apr2021 at 08:00 the patient experienced tingles on his right hand fingers and right leg. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event  tingles on his right hand fingers and right leg was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever; Chills; Body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 25Apr2021 at 10:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa antibiotics (sulfonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. On 26Apr2021 at 00:00 the patient experienced fever, chills and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills and body aches was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: Headaches (consistent) within 5 hours of dose,; Exhaustion the next day; Consistent 102F temperature through day 3 and 4; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 29-years-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Concomitant medications included fexofenadine hydrochloride (ALLEGRA 24 HOUR) for an unspecified indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, within five hours of the dose, the patient experienced headaches (consistent). On an unknown date, the next day of vaccination, the patient experienced exhaustion. On an unknown date, through day three and four of vaccination, the patient experienced consistent 102 degrees Fahrenheit temperature. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headaches (consistent) within 5 hours of dose, exhaustion the next day and consistent 102 degrees Fahrenheit temperature was resolving at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia, Tremor
Clinical narrative: Chills; Fever; Shaking; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm left on 26Apr2021 at 10:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included allergy to sulfa. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medication was not reported. The patient previously took cefaclor (CECLOR) on an unknown date and experienced allergy. On 26Apr2021 at 23:00, the patient experienced chills, fever, shaking, headache and nausea. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, shaking, headache and nausea were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on arms back legs torso; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 27Apr2021 at 11:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included finasteride (MANUFACTURER UNKNOWN) and simvastatin (MANUFACTURER UNKNOWN); both taken for unknown indications from an unknown date and unknown if ongoing. On 27Apr2021 at 17:00, the patient experienced rash on arms back legs torso. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on arms back legs torso was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy, Nasal congestion
Clinical narrative: Swollen lymph node on armpit at the side of injection; Slight stuffed nose; Chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. An 18-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 12:15 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 24Apr2021, at 02:00, the patient experienced chills and headache, slight stuffed nose, swollen lymph node on armpit at the side of injection. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills and headache, slight stuffed nose, swollen lymph node on armpit at the side of injection was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus in both ears a few days after vaccine/Also what felt like an autoimmune flair; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The medical history included post lyme syndrome and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D) and calcium (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. On 02Apr2021, a few days after vaccination, the patient experienced tinnitus in both ears. The patient never had this before and it was persistent and also what felt like an autoimmune flair. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus in both ears was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspepsia, Nausea, Tremor, Vomiting
Clinical narrative: Violent body shaking; Complete loss of appetite; Sour stomach; Nausea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 20Apr2021 at 15:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ollie women's multivitamin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received azithromycin (ZITHROMAX) on an unknown date for an unknown indication and experienced drug allergy. On 20Apr2021 at 16:45, the patient experienced violent body shaking, complete loss of appetite, sour stomach, nausea and vomiting (once). The patient wasn't sure if she needed to consult a doctor. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events violent body shaking, complete loss of appetite, sour stomach, nausea and vomiting (once) were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.